Summit Therapeutics PLC Free Cash Flow Generation Index

Latest as of December 2022: 1.00x

Summit Therapeutics PLC free cash flow generation index. Summit Therapeutics PLC (SMMT) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $4.24 Million represents 1% of operating cash flow ($4.23 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$4.24 Million
USD

Operating Cash Flow

$4.23 Million
USD

Capital Expenditures

$994.38K
USD

Free Cash Flow Generation Index of Summit Therapeutics PLC (2004–2016)

Free cash flow generation index of Summit Therapeutics PLC from 2004 to 2016. Historical FCF Generation Index trend for Summit Therapeutics PLC across 2 annual periods. See financial flexibility index of Summit Therapeutics PLC to measure the company's free cash flow as a share of total liabilities.

Summit Therapeutics PLC Free Cash Flow Generation Index by Year (2004–2016)

Summit Therapeutics PLC free cash flow generation index by year from 2004 to 2016. Year-by-year Free Cash Flow Generation Index for Summit Therapeutics PLC. For the full cash flow conversion analysis, see SMMT cash generation efficiency.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2016 0.99x $15.07 Million $15.18 Million $110.00K ▼ -31.8%
2004 1.46x $43.30K $29.74K $13.18K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).